University of Wollongong

Research Online
Australian Health Services Research Institute

Faculty of Business and Law

1-1-2019

Emerging role of the Australian private health insurance sector in providing
chronic disease management programs: Current activities, challenges and
constraints
Joanna Khoo
University of Wollongong, Capital Markets CRC Ltd, jk645@uowmail.edu.au

Helen M. Hasan
University of Wollongong, hasan@uow.edu.au

Kathy Eagar
University of Wollongong, keagar@uow.edu.au

Follow this and additional works at: https://ro.uow.edu.au/ahsri

Recommended Citation
Khoo, Joanna; Hasan, Helen M.; and Eagar, Kathy, "Emerging role of the Australian private health
insurance sector in providing chronic disease management programs: Current activities, challenges and
constraints" (2019). Australian Health Services Research Institute. 1018.
https://ro.uow.edu.au/ahsri/1018

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Emerging role of the Australian private health insurance sector in providing
chronic disease management programs: Current activities, challenges and
constraints
Abstract
Objective
Objective: This study explored the current activities of a sample of Australian private health insurance
(PHI) funds to support the care of people living with chronic conditions, following changes to PHI
legislation in 2007 permitting funds to cover a broader range of chronic disease management (CDM)
services.
Methods
Methods: A qualitative research design was used to gather perspectives from PHI sector representatives
via semistructured interviews with eight participants. The interview data were analysed systematically
using the framework analysis method.
Results
Results: Three main types of activities were most commonly identified: (1) healthcare navigation (2)
structured disease management and health coaching programs and (3) care coordination services. These
activities were primarily conducted via telephone by a combination of in-house and third-party health
professionals. PHI funds seem to be taking a pragmatic approach to the type of CDM activities currently
offered, guided by available data and identified member need. Activities are focused on people with
diagnosed chronic conditions exiting hospital, rather than the broader population at-risk of developing a
chronic condition.
Conclusions
Conclusions: Despite legislation permitting PHI funds to pay benefits for CDM services being in place for
more than 10 years, insurers are still in an early stage of implementation and evaluation of CDM activities.
Primarily due to the regulated scope of PHI coverage in Australia, participants reported several challenges
in providing CDM services, including identifying target groups, evaluating service outcomes and
collaborating with other healthcare providers. The effectiveness of the approach of PHI funds to CDM in
terms of the groups targeted and outcomes of services provided still needs to be established because
evidence suggests that population-level interventions that target a larger number of people with lower
levels of risks are likely to have greater benefit than targeting a small number of high-risk cases.
What is known about the topic?
topic?: Since 2007, PHI funds in Australia have been able to pay benefits for a
range of out-of-hospital services, focused on CDM. Although a small number of program evaluations has
been published, there is little information on the scope of activities and the factors influencing the design
and implementation of CDM programs.
What does this paper add?
add?: This paper presents the findings of a qualitative study reporting on the CDM
activities offered by a sample of PHI funds, their approach to delivery and the challenges and constraints
in designing and implementing CDM activities, given the PHI sector's role as a supplementary health
insurer in the Australian health system.
What are the implications for practitioners?
practitioners?: Current CDM activities offered by insurers focus on health
navigation advice, structured, time-limited CDM programs and care coordination services for people
following a hospital admission. There is currently little integration of these programs with the care
provided by other health professionals for a person accessing these services. Although the role of
insurers is currently small, the movement of insurers into service provision raises considerations for
managing potential conflicts in having a dual role as an insurer and provider, including the effectiveness
and value of services offered, and how these programs complement other types of health care being
received.
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Abstract
Objective. This study explored the current activities of a sample of Australian private health insurance (PHI) funds to
support the care of people living with chronic conditions, following changes to PHI legislation in 2007 permitting funds to
cover a broader range of chronic disease management (CDM) services.
Methods. A qualitative research design was used to gather perspectives from PHI sector representatives via
semistructured interviews with eight participants. The interview data were analysed systematically using the framework
analysis method.
Results. Three main types of activities were most commonly identiﬁed: (1) healthcare navigation; (2) structured
disease management and health coaching programs; and (3) care coordination services. These activities were primarily
conducted via telephone by a combination of in-house and third-party health professionals. PHI funds seem to be taking a
pragmatic approach to the type of CDM activities currently offered, guided by available data and identiﬁed member need.
Activities are focused on people with diagnosed chronic conditions exiting hospital, rather than the broader population atrisk of developing a chronic condition.
Conclusions. Despite legislation permitting PHI funds to pay beneﬁts for CDM services being in place for more than
10 years, insurers are still in an early stage of implementation and evaluation of CDM activities. Primarily due to the
regulated scope of PHI coverage in Australia, participants reported several challenges in providing CDM services, including
identifying target groups, evaluating service outcomes and collaborating with other healthcare providers. The effectiveness
of the approach of PHI funds to CDM in terms of the groups targeted and outcomes of services provided still needs to be
established because evidence suggests that population-level interventions that target a larger number of people with lower
levels of risks are likely to have greater beneﬁt than targeting a small number of high-risk cases.
What is known about the topic? Since 2007, PHI funds in Australia have been able to pay beneﬁts for a range of out-ofhospital services, focused on CDM. Although a small number of program evaluations has been published, there is little
information on the scope of activities and the factors inﬂuencing the design and implementation of CDM programs.
What does this paper add? This paper presents the ﬁndings of a qualitative study reporting on the CDM activities offered
by a sample of PHI funds, their approach to delivery and the challenges and constraints in designing and implementing CDM
activities, given the PHI sector’s role as a supplementary health insurer in the Australian health system.
What are the implications for practitioners? Current CDM activities offered by insurers focus on health navigation
advice, structured, time-limited CDM programs and care coordination services for people following a hospital admission.
There is currently little integration of these programs with the care provided by other health professionals for a person
accessing these services. Although the role of insurers is currently small, the movement of insurers into service provision
raises considerations for managing potential conﬂicts in having a dual role as an insurer and provider, including the
effectiveness and value of services offered, and how these programs complement other types of health care being received.
Additional keywords: health funding and ﬁnancing, health systems, information management, population health.
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Introduction
Chronic disease management (CDM) refers to an intervention
designed to manage or prevent a chronic condition using a
systematic approach to care, and potentially using multiple
treatment modalities.1 A broad range of interventions can be
categorised as CDM, including care coordination, health coaching, risk appraisal and health promotion.2 Since 2007, private
health insurance (PHI) funds in Australia have been able to pay
beneﬁts for a broader range of services focused on health and
disease management, including CDM programs.3 Australia is not
unique in having a health insurance sector offering CDM programs, with insurers in other countries, including the US and
Germany, offering these programs for several years.4,5
Recent research on the PHI sector’s involvement in primary
health care in Australia and the implications for health equity
reported a range of insurer activities, including enhanced access
to general practitioner (GP) services, CDM and risk factor
prevention programs, mental health programs and hospital transition support programs.6 Evaluations of a small number of
programs offered by large PHI funds to support people with
chronic conditions have been published; these studies report
mixed results in relation to improved health status, reduction in
service utilisation and cost-effectiveness.7–10 These evaluation
studies focus on outcomes, primarily use of health services and
healthcare costs, but do not provide insight into the processes of
designing and implementing CDM programs, which is the focus
of the present study.
The need for high-quality health information has been recognised as a key feature of models of care for people with chronic
conditions, with clinical information systems and decision support being two of the six system-level factors in the widely used
chronic care model.11,12 Information on an individual’s current
and changing health status is required to appropriately target
CDM activities. However, PHI information systems were
designed to facilitate the payment of claims, not support health
and disease management, and PHI funds do not have direct
access to clinical information; instead, they rely on both patients
and healthcare providers to share data with them.13 Hospital
claims data are currently the most comprehensive data source
available to Australian PHI funds, but their suitability for selecting people in need of CDM support is unknown.
Analysing the role of the PHI sector in supporting people with
chronic conditions has not been researched in the Australian
context. Previous research on the care needs of older Australians
with multiple chronic conditions reported beneﬁts and challenges of maintaining PHI, including considerable ﬁnancial
pressure to maintain insurance and access to private hospital
care.14 This research did not report on speciﬁc services accessed
by the study participants. The present study focused on the
perspective of PHI funds and investigated the different
approaches used by PHI funds to support people with chronic
conditions, as well as the factors inﬂuencing the design and
implementation of CDM strategies, particularly data and information requirements. The study focused on the perspectives of
smaller, non-proﬁt PHI funds that have diverse membership
proﬁles and operational environments due to their origins as
restricted membership organisations and mutual societies serving a speciﬁc employee sector or geographic location.15 As a
result of these distinct characteristics, these PHI funds may take a
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different approach to designing and implementing CDM programs than the larger funds that have published evaluations of
CDM programs.
Methods
The study used a qualitative research design with in-depth,
semistructured interviews to explore PHI fund approaches to
offering CDM activities, as well as challenges and constraints
in designing and implementing strategies. Semistructured interviews were selected because this method allows a depth of
response from each participant.16
Sample
Participant sampling was criterion based. All participants had
to be presently working in the PHI sector and hold a senior
management role. Invitations to participate were sent via email
to 19 PHI organisations. A target of 8–10 interviews was set,
but a principle of saturation was used whereby interviews
would continue until no new themes emerged.17 Saturation
was reached after eight interviews and no new interviews were
scheduled. Participant and fund characteristics are presented in
Table 1. Participants came from seven different PHI funds and
one PHI industry association, representing approximately 20%
of registered PHI funds in Australia. The participants reﬂect a
diversity of perspectives based on fund size and level of PHI
sector experience. The length of PHI sector experience of
participants ranged from 1 to 20 years, with three participants
employed for less than 2 years in the PHI sector and ﬁve
participants employed for more than 2 years. Four of the
participants interviewed were employed in clinical or health
care-related roles focused on CDM services. In relation to the
seven PHI funds represented, four funds had less than 100 000
members in total and three funds had between 100 000 and
400 000 members.
Procedure
The email invitations sent to senior managers within PHI organisations described that the purpose of the interview was to

Table 1. Participant and insurance fund characteristics
CEO, chief executive ofﬁcer; PHI, private health insurance
Participant characteristics
Sex
Female
Male
Time employed in the PHI
sector (years)
2
>2 (maximum 20 years)
Management level

n Fund characteristics

n

6
2

Fund size (no. individual members)
<100 000
4
100 000–400 000
3
Type of fund

3
5

4
3

CEO
Executive management:
insurance
Executive management:
4
clinical or healthcare focus

2
1

Open fund
Restricted member fund
Concentration of membership
(>50% members)
2
New South Wales
2
Victoria
Queensland

3

No geographical concentration

1
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discuss the design and implementation of CDM programs. Due to
the seniority of the participants, conﬁrmation to participate in the
interview through reply email to schedule an interview time was
deemed consent to participate in the research.
Interviews were conducted via telephone, with the duration of
interviews lasting from 30 to 60 minutes. Explicit consent was
gathered from each participant at the beginning of the interview
to audio record the interview for the purposes of transcription.
The interview schedule was sent to participants 2 weeks before
the interview. The study protocol was reviewed by the university
institute that the researchers are afﬁliated with, the Australian
Health Services Research Institute at the University of Wollongong, and deemed to be negligible risk research, and thus exempt
from ethics review.
Interview schedule
The interview schedule was piloted with an individual with both
research and PHI sector experience, and the ﬁnal schedule was
minimally revised following feedback. Interview questions relevant to the ﬁndings presented in this paper are listed below.
1. What is your perception of the role of PHI funds in CDM?
2. Can you brieﬂy tell me about the current strategies that your
fund uses to support people living with chronic diseases?
3. From your perspective, what is the most important information needed to design and implement CDM programs?
4. Can you comment on the adequacy of the data sources
currently used by your fund to inform CDM programs?
5. How does your fund measure success in CDM programs?
6. Do you have any suggestions for recommendations that
would help shape the future that you want to see for the PHI
sector in the area of CDM?
Data analysis
The interviews were transcribed and analysed following the
framework analysis method.18 This method was developed for
applied policy research and has been described as particularly
suited to qualitative studies with speciﬁc questions, a priori issues
and a predesigned sample,19 which aligned with the circumstances of this study. The ﬁve stages of framework analysis are
familiarisation, identifying a thematic framework, indexing,
charting, mapping and interpretation. Following familiarisation
with the data, a thematic framework was developed and transcripts were systematically indexed, then charted into a spreadsheet. Mapping and interpretation linked the thematic areas back
to the study aim and key areas of investigation. A process of
member checking was conducted whereby analysed results were
returned to participants for their review and validation.20

Results
Current CDM activities of PHI funds
All participants responded that their fund currently offers services to support insured members with chronic conditions,
although these services were at different stages of maturity,
ranging from funds that have established separate businesses to
provide health and disease management programs to a fund with
only one person dedicated to supporting the CDM needs of
members. The main categories of CDM activities offered by
PHI funds, activity eligibility criteria, mode of delivery and
provider type are given in Table 2. Four participants reported that
their fund offered telephone-based health navigation services
provided by in-house staff. Any health fund member can call staff
working in the navigation services to ask speciﬁc questions about
the health and aged care systems, and for speciﬁc healthcare
provider referrals. Four participants reported that their fund had
contracts with third-party providers to offer telephone-based
disease management and health coaching programs. These programs often focus on speciﬁc chronic conditions, such as diabetes, cardiovascular disease and mental health conditions,
although some participants offered more general programs referred to as ‘health coaching’, in which tailored care plans were
developed with individuals based on their speciﬁc health goals.
Participants in these programs were recruited based on hospital
claims data analysis and member self-referral.
Five participants reported that their fund offered care coordination services, predominantly provided via telephone with inhouse staff. Care coordination services had the most detailed
eligibility criteria for participation, including age (targeting older
members aged >55 years) with at least one chronic disease
diagnosis and high levels of hospital use (e.g. more than two
hospitalisations in the past 2 years). Care coordination services
were targeted at patients leaving hospital, with people identiﬁed
before admission when clarifying patient eligibility for hospital
beneﬁts or after admission when insurance claims are received.
Care coordination services involved an assessment and development of a care plan that identiﬁed speciﬁc supports that an
individual would receive after hospitalisation, including nursing,
allied health and meal delivery services.
Disease management and health coaching programs and care
coordination services are offered as time-limited services, generally lasting from an initial period of 6 weeks to 3 months, and
extending up to 12 months. All funds employ at least one staff
member with a clinical background. The type of clinical positions
employed varied across funds. The most common profession was
registered nurse, but other clinicians included dieticians, pharmacists and mental health nurses.

Table 2. Chronic disease management activities offered by private health insurance funds, showing the number of funds offering a service by mode
of delivery and provider type
Activity eligibility criteria

Health navigation
Disease management
and health coaching programs
Care coordination services

Open to all members
Member self-referral and identiﬁcation
through hospital admissions
Speciﬁc criteria based on hospital admission

Mode of delivery

Provider type

Telephone based

Face to face

In-house

Third party

4
4

–
–

4
–

–
4

4

1

4

1
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In addition to the three activity categories, multiple participants
also reported that their fund offered hospital substitution programs
and education activities aimed at improving health literacy.
Hospital substitution programs referred to a range of nursing
services delivered at home. The existence of these services enable
patients to be discharged earlier from hospital after surgical
procedures. ‘Education activities to improve health literacy’ was
a broad term used to refer to both marketing and communication
materials distributed to the entire insured population, as well as
targeted information provided to people enrolled in CDM programs that may assist them to self-manage their condition.
Information requirements and data sources for CDM
implementation and evaluation
Hospital claims data were the main source of data used to identify
people to participate in CDM activities. Six funds ran reports to
identify patients with speciﬁc chronic conditions, determined by a
listofclinicaldiagnosis codes. Funds alsoreviewed hospitalclaims
datatoidentify patients withmultiple hospitalisations,longlengths
of stay and high-cost episodes. Participant responses related to data
and information requirements for CDM frequently referred to
limitations of current data sources. The major limitation, noted by
six respondents, is information onhealth status for people withouta
hospitalisation, particularly indicators of disease risk.
We do need good claiming data, accurate claiming data,
and being able to put that all together, but the bit that we
don’t have right now is some kind of really good risk
identiﬁer. (Participant 2)
Realistically, we need GP data, I think, to be effective in
fully identifying those people before they end up with a
chronic disease. (Participant 8)
Indicators to evaluate and measure the success of CDM
programs ranged from measures of program awareness, participation and satisfaction to more sophisticated measures to assess
the effectiveness of the program, in terms of both its clinical or
health effects and ﬁnancial effect. Clinical measures included
changes in weight and stress levels and assessment of quality of
life. Financial measures included changes in service utilisation,
such as the number of hospital admissions, length of stay, hospital
readmission rates and costs of care paid by the insurer. Despite this
broad range of measures, most participants acknowledged shortcomings in their approach to evaluating CDM programs and that
formal program evaluations, if planned, were in the early stages.
There’s no point paying for services that have no ability to
realise the beneﬁts, but I do worry that we are not measuring or assessing the right things when it comes to the
evidence base. (Participant 1)
. . .in terms of a real evaluation or impact framework still
very early on. So, that’s a key piece that we’ve got scoped
up. (Participant 4)
Constraints and challenges affecting the role of PHI funds in
offering CDM activities
Most participants responded that PHI sector regulations constrain aspects of their role in supporting people with chronic
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conditions. These regulatory issues were both broad, referring to
the framework in which the PHI sector operates, and narrow,
noting speciﬁc restrictions on the types of services that can be
funded by PHI policies.
I think there is a need for simpliﬁcation of the legislation to
support funds in providing chronic disease management
and that’s not without acknowledging, I guess, the complex
dynamics about community rating, risk equalisation, adverse selection and portability. (Participant 1)
One example is telehealth, we can’t pay beneﬁts for that at
the moment for allied health professionals so some ﬂexibility in the way that care is being delivered in the future
will be beneﬁcial. (Participant 8)
Participants reported challenges in negotiating an expanded
role in offering CDM activities by PHI funds within the Australian healthcare system, particularly in building relationships
with GPs and other healthcare providers.
It’s certainly been one of our biggest hurdles to get some
level of respect with GPs and some level of trust and I think
we’re very, very slowly getting there. (Participant 7)
Despite these constraints, PHI funds were generally optimistic about their future role in supporting CDM.
I think there’s a tremendous opportunity for us, and as little
funds we might have to band together to actually make
them cost-effective. If we could work effectively with
primary health care and support, like a two-way support
of each other, with primary healthcare providers. (Participant 2)
I’d like to see that we’re an insurance and care company
that we are actually sharing the health journey with
someone and insurance is one of those products that
support you. (Participant 4)
Discussion
The purpose of this study was to explore the emerging role of
Australian PHI funds in providing CDM programs. The study
ﬁndings indicate that all funds were implementing strategies to
support people with chronic conditions, but these strategies were
at different stages of maturity. Although there were different
approaches in relation to organisational arrangements and inhouse versus outsourced service provision, there were similarities in the types of activities offered, with three main activity
categories reported by participants: (1) health navigation; (2)
disease management and health coaching programs; and (3) care
coordination services. CDM activities currently supported by
PHI funds seem to be guided by a pragmatic approach based on
available data and identiﬁed member need. Hospital claims data
are the primary data source used to identify participants for CDM
activities, so activities are focused on people with diagnosed
chronic conditions exiting hospital, rather than the population at
risk of developing a chronic condition.
The current approach of PHI funds to offering CDM programs
does not represent a comprehensive approach across the
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spectrum of disease risk of the population. Australian PHI funds
recognise the limitations of their current approach, but face
several challenges in implementing CDM programs. PHI funds
are prevented by legislation from covering out-of-hospital medical services covered by Medicare, including GPs and specialist
physician consultations. As noted by participants, this limits
insurers’ ability to understand an individual’s broader health
service utilisation and to identify people to participate in programs at earlier stages of disease risk, before hospitalisation. The
effectiveness of this approach in improving the health status of
members is yet to be demonstrated because PHI funds are at the
early stages of evaluating their programs. The ‘prevention
paradox’ introduced by Geoffrey Rose21 suggests that targeting
large numbers of people at earlier stages of disease risk will have
a greater effect on population health improvement than targeting
a smaller number of high-risk individuals.
Targeting at-risk groups and providing broader CDM services
may require collaboration with health providers, including analysing disparate data sources to build a more comprehensive
picture of the health and healthcare journey of the target member
population, but most PHI funds have limited experience in
community-based health management and lack linkages with
service providers, particularly in primary care. In addition,
healthcare providers and patients view the primary function of
insurers as businesses that pay for health services (although many
smaller funds in Australia operate on a not-for-proﬁt basis) and
may be wary in sharing additional health information with
insurers. It is important to note that ethical issues relating to
insurers having greater access to health information are somewhat offset by the current system of community rating enshrined
in the Private Health Insurance Act (2007) that means that
insurers cannot charge differential premiums to people with
differing levels of disease risk.
Despite optimism for the future role of PHI funds in supporting people with chronic conditions, several tensions related to the
value proposition of PHI CDM activities were expressed in this
study. Although government regulation has supported PHI funds
having a role in CDM since 2007, the interviews suggest there are
still questions of legitimacy related to the role of PHI. Most
participants responded that they were providing care navigation
and care coordination services, but there are other potential
providers of these services in the Australian health system, such
as enhanced primary care services involving nurses22 and community pharmacies.23 Ultimately, the CDM services offered by
PHI funds need to be seen by both patients and providers as
effective for them to be taken up and sustainable in the future. PHI
funds that, in recent years, have introduced an increasing number
of insurance policies with health service exclusions or excess
copayments24 may not naturally be regarded as the best ﬁt for
providing CDM services, and patients may even perceive a
conﬂict of interest in receiving CDM services from the same
organisation to which they pay insurance premiums, despite
efforts to delineate functions within insurers.
This study found that most current CDM programs supported
by PHI funds, either provided in-house or supported by a
third party, are yet to be evaluated. Evidence of effectiveness
may be an important component of future viability because, from
a resourcing perspective, these programs require ongoing
allocation of ﬁnancial and human resources. The positive effect
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of PHI-supported CDM activities should not be assumed, and
should be demonstrated through formal program evaluations.
The study ﬁndings suggest that the PHI sector will struggle to
expand its role in CDM in the absence of broader business and
policy transformation related to data availability and relationships with both patients and providers.
This study has several limitations and caution needs to be
taken in generalising study ﬁndings. The participants interviewed in this study represent only a sample of Australian PHI
funds. The study presented the perspective of smaller, non-proﬁt
funds that have not been represented in previous PHI sector
research. The research design focused on the perspective of PHI
funds providing CDM services, but the perspective of other
stakeholders, particularly patients receiving services funded by
PHI funds, would be a valuable area of future research.
Conclusion
PHI funds in Australia want to expand beyond the traditional role
of an insurer to offer CDM services. However, despite legislation
permitting funds to pay beneﬁts for CDM activities for more than
10 years, insurers are still in an early stage of implementation and
evaluation of CDM activities, with the main category of activities
being health navigation, disease management and health coaching programs and care coordination services. PHI funds have
experienced several challenges in expanding CDM activities
related to regulatory constraints, information gaps and relationships with other healthcare stakeholders, including patients and
providers.
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